Mielodiszplasztikus szindróma (MDS): vizsgálatok itt: Hollandia
8 trials · From ClinicalTrials.gov, checked 2026. november 17.. Ask the study team whether a trial fits you.
- 3. fázisTaking peoplePhase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
- Where
- Amersfoort, Amsterdam, Arnhem, Breda, Delft, Den Bosch, Den Haag, Dordrecht, Eindhoven, Enschede, Groningen, Leeuwarden, Leiden, Maastricht, Nieuwegein, Nijmegen, Rotterdam, Utrecht, Zwolle
- Életkor
- 18 év to 75 év
- People
- 650 worldwide
- Run by
- University of Ulm
See details and how to joinNCT04628026 · EU 2023-507518-28-00 - 3. fázisNot yet taking people in HollandiaA Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Takeda
See details and how to joinNCT07422480 · EU 2025-523544-12-00 - 1. fázisNot yet taking people in HollandiaFirst-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
- Where
- Groningen, Rotterdam
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Genmab
See details and how to joinNCT07384715 · EU 2025-523101-15-00 - 2. fázisFut, nem toboroz(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 3. fázisTaking peopleIvosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
- Where
- Amsterdam, Groningen
- Életkor
- 18 év and over
- People
- 48 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT06465953 · EU 2023-510155-37-00 - 1/2. fázisNot yet taking people in HollandiaA Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
- Where
- Amsterdam, Groningen, Maastricht, Nijmegen
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Servier
See details and how to joinNCT07719348 · EU 2025-525128-88-00 - 3. fázisBefejeződöttA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060 - 1/2. fázisFelfüggesztveStudy to Evaluate the Safety and Tolerability of EP0042
- Where
- Amsterdam, Rotterdam
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Ellipses Pharma
See details and how to joinNCT04581512 · EU 2024-514588-24-00